The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition
- Resource Type
- Review Article
- Source
- In
Annals of Oncology October 2021 32(10):1236-1244 - Subject
- Language
- ISSN
- 0923-7534